Related Experiment Video

Updated: Apr 27, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.0K

Endothelial dysfunction in chronic inflammatory diseases

Curtis M Steyers1, Francis J Miller2

  • 1Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA. curtis-m-steyers@uiowa.edu.

International Journal of Molecular Sciences
|June 27, 2014
PubMed

Insights

Chronic inflammatory diseases accelerate atherosclerosis and cardiovascular disease (CVD) risk by causing endothelial dysfunction. Targeting tumor necrosis factor-alpha (TNF-α) may reduce this risk.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Rheumatology

Background:

  • Chronic inflammatory diseases share pathogenic links with atherosclerosis, a major cause of cardiovascular disease (CVD).
  • Endothelial dysfunction is a critical early event in atherosclerosis and is prevalent in patients with systemic inflammatory conditions.
  • Understanding the interplay between systemic inflammation and vascular health is crucial for CVD prevention.

Purpose of the Study:

  • To explore the mechanisms linking chronic inflammatory diseases to endothelial dysfunction and accelerated atherosclerosis.
  • To highlight the endothelium as a key site for understanding the relationship between systemic inflammation and CVD.
  • To investigate the potential of anti-inflammatory therapies, specifically those targeting tumor necrosis factor-alpha (TNF-α), in mitigating cardiovascular risk.

Main Methods:

  • Review of current literature on atherosclerosis, chronic inflammatory diseases, and endothelial function.
  • Analysis of factors contributing to endothelial activation in inflammatory conditions, including cytokines, oxidative stress, and lipoproteins.
  • Discussion of the role of endothelial dysfunction as a marker for cardiovascular events.

Main Results:

  • Systemic inflammatory diseases are associated with early endothelial dysfunction, contributing to atherosclerosis.
  • Multiple inflammatory mediators (e.g., TNF-α, reactive oxygen species, oxidized LDL) activate endothelial cells, impairing vascular function.
  • Endothelial dysfunction manifests as reduced vascular relaxation, increased leukocyte adhesion, and a pro-thrombotic state.

Conclusions:

  • Endothelial dysfunction is a central mechanism linking chronic inflammatory diseases to accelerated atherosclerosis and cardiovascular disease.
  • Targeting inflammatory pathways, such as TNF-α, holds promise for reducing endothelial dysfunction and CVD risk in these patients.
  • Elucidating these mechanisms can advance our understanding of atherosclerosis in the general population.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.6K

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
24
Inflammation01:38

Inflammation

Overview
46.3K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
48
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
27